These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 17909067

  • 1. Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.
    Ruiz-Llorente S, Montero-Conde C, Milne RL, Moya CM, Cebrián A, Letón R, Cascón A, Mercadillo F, Landa I, Borrego S, Pérez de Nanclares G, Alvarez-Escolá C, Díaz-Pérez JA, Carracedo A, Urioste M, González-Neira A, Benítez J, Santisteban P, Dopazo J, Ponder BA, Robledo M, Medullary Thyroid Carcinoma Clinical Group.
    Cancer Res; 2007 Oct 01; 67(19):9561-7. PubMed ID: 17909067
    [Abstract] [Full Text] [Related]

  • 2. RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.
    Fugazzola L, Muzza M, Mian C, Cordella D, Barollo S, Alberti L, Cirello V, Dazzi D, Girelli ME, Opocher G, Beck-Peccoz P, Persani L.
    Clin Endocrinol (Oxf); 2008 Sep 01; 69(3):418-25. PubMed ID: 18284634
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.
    Cebrian A, Lesueur F, Martin S, Leyland J, Ahmed S, Luccarini C, Smith PL, Luben R, Whittaker J, Pharoah PD, Dunning AM, Ponder BA.
    J Clin Endocrinol Metab; 2005 Nov 01; 90(11):6268-74. PubMed ID: 16091499
    [Abstract] [Full Text] [Related]

  • 4. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.
    Fernández RM, Peciña A, Antiñolo G, Navarro E, Borrego S.
    Thyroid; 2006 Apr 01; 16(4):411-7. PubMed ID: 16646689
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation.
    Tamanaha R, Camacho CP, Pereira AC, da Silva AM, Maciel RM, Cerutti JM.
    Clin Endocrinol (Oxf); 2009 Jul 01; 71(1):56-64. PubMed ID: 19138318
    [Abstract] [Full Text] [Related]

  • 6. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK, MacRae C, Ifeacho S, Robinson S, Tolley NS.
    J Laryngol Otol; 2009 Jul 01; 123(7):796-800. PubMed ID: 18771606
    [Abstract] [Full Text] [Related]

  • 7. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
    Cardot-Bauters C, Leteurtre E, Leclerc L, Vantyghem MC, Do Cao C, Wemeau JL, d'Herbomez M, Carnaille B, Barbu V, Pinson S, Pigny P, Groupe d'Etude des Tumeurs Endocrines (GTE).
    Clin Endocrinol (Oxf); 2008 Sep 01; 69(3):506-10. PubMed ID: 18331611
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.
    Fernández RM, Navarro E, Antiñolo G, Ruiz-Ferrer M, Borrego S.
    Int J Mol Med; 2006 Apr 01; 17(4):575-81. PubMed ID: 16525712
    [Abstract] [Full Text] [Related]

  • 9. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
    Milne RL, Ribas G, González-Neira A, Fagerholm R, Salas A, González E, Dopazo J, Nevanlinna H, Robledo M, Benítez J.
    Cancer Res; 2006 Oct 01; 66(19):9420-7. PubMed ID: 17018596
    [Abstract] [Full Text] [Related]

  • 10. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
    McWhinney SR, Boru G, Binkley PK, Peczkowska M, Januszewicz AA, Neumann HP, Eng C.
    J Clin Endocrinol Metab; 2003 Oct 01; 88(10):4911-6. PubMed ID: 14557473
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms Within the RET Proto-Oncogene and Risk of Sporadic Medullary Thyroid Carcinoma.
    Gemignani F, Romei C, Ciampi R, Corrado A, Melaiu O, Figlioli G, Bonotti A, Foddis R, Cristaudo A, Pellegrini G, Vivaldi A, Cipollini M, Landi S, Elisei R.
    Thyroid; 2020 Nov 01; 30(11):1579-1588. PubMed ID: 32228166
    [Abstract] [Full Text] [Related]

  • 12. Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.
    Gallel P, Pallares J, Dolcet X, Llobet D, Eritja N, Santacana M, Yeramian A, Palomar-Asenjo V, Lagarda H, Mauricio D, Encinas M, Matias-Guiu X.
    Hum Pathol; 2008 Jul 01; 39(7):994-1001. PubMed ID: 18508109
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer.
    Borrego S, Fernández RM, Dziema H, Japón MA, Marcos I, Eng C, Antiñolo G.
    Thyroid; 2002 Nov 01; 12(11):1017-22. PubMed ID: 12490080
    [Abstract] [Full Text] [Related]

  • 14. RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.
    Abdelhakim A, Barlier A, Kebbou M, Benabdeljalil N, Timinouni M, Taoufiq F, Roche C, El Antri S.
    J Cancer Res Ther; 2009 Nov 01; 5(3):198-202. PubMed ID: 19841562
    [Abstract] [Full Text] [Related]

  • 15. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP.
    Endocr Relat Cancer; 2008 Dec 01; 15(4):1035-41. PubMed ID: 18794325
    [Abstract] [Full Text] [Related]

  • 16. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.
    Alvandi E, Akrami SM, Chiani M, Hedayati M, Nayer BN, Tehrani MR, Nakhjavani M, Pedram M.
    Thyroid; 2011 Apr 01; 21(4):373-82. PubMed ID: 21309721
    [Abstract] [Full Text] [Related]

  • 17. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.
    Endocr Relat Cancer; 2010 Dec 01; 17(4):953-63. PubMed ID: 20801952
    [Abstract] [Full Text] [Related]

  • 18. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
    Shifrin AL, Xenachis C, Fay A, Matulewicz TJ, Kuo YH, Vernick JJ.
    Surgery; 2009 Dec 01; 146(6):998-1005. PubMed ID: 19958926
    [Abstract] [Full Text] [Related]

  • 19. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
    Wiench M, Włoch J, Wygoda Z, Gubała E, Oczko M, Pawlaczek A, Kula D, Lange D, Jarzab B.
    Cancer Detect Prev; 2004 Dec 01; 28(4):231-6. PubMed ID: 15350625
    [Abstract] [Full Text] [Related]

  • 20. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
    Abraham DT, Low TH, Messina M, Jackson N, Gill A, Chou AS, Delbridge L, Learoyd D, Robinson BG, Sidhu S, Sywak M.
    Ann Surg Oncol; 2011 Jan 01; 18(1):219-25. PubMed ID: 20878247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.